It’s time to announce the five finalists selected to compete for the #SLASEurope2026 Student Poster Award. Here's CEO Vicki Loise for the official announcement...

From SLAS Discovery: Faster Cell Painting, sharper insights. Early readouts (~6h) capture primary drug effects more accurately than standard 48h assays boosting specificity, reducing noise, and accelerating high-throughput screening workflows. https://ow.ly/toPm50YMkjj

From NIH: New assay, new clues for neurotoxicity. A CRISPR-engineered MT1G::HiBiT neuronal model enables high-throughput screening linking metal-chelating compounds to neurotoxic signals and advancing discovery of Parkinson’s risk factors. https://ow.ly/mOgY50YMkh6

From OMass Therapeutics: New tool for ion channel discovery: the “Glorider” BRET biosensor tracks chloride dynamics in real time in living cells enabling high-throughput screening of WNK, KCC2, and NKCC1 modulators for drug development. https://ow.ly/xlyw50YMkgj

Join us at ETH Zurich next Thursday for an afternoon of discussion and networking featuring Olivier Frey, Dr. Sc (InSphero), who will present “Scaling up 3D cell-based assays in numbers and information content.” https://bit.ly/4d5KI7F

m6A RNA modification is emerging as a key regulator of lipid metabolism—linking epigenetics to diseases like obesity, NAFLD, and atherosclerosis. Targeting m6A pathways could unlock new therapeutic strategies for metabolic disease. https://ow.ly/UC3r50YMkfc

From SLAS Discovery: New front in the fight against antibiotic resistance: bacterial cytoskeleton & division systems (BCRDs). This review highlights untapped drug targets and combo strategies to outmaneuver resistance and spark next-gen antibiotic development. https://ow.ly/9oOb50YMkcS

One important #SLASEurope2026 abstract deadline remains. Shine a spotlight on your research and connect with other life sciences and lab automation technology professionals while in Vienna for this year's conference and exhibition. View details: https://bit.ly/3OTwQFe#SLASEurope2026

From SLAS Discovery: Small but mighty. Nanobodies derived from camelids show strong potential against respiratory viruses like SARS-CoV-2 and flu, offering stable, cost-effective, and highly specific options for antiviral therapy and diagnostics. https://ow.ly/eSgj50YMkcr

From SLAS Discovery: Tiny fish, big impact. Zebrafish models are emerging as powerful tools for drug and quantum dot toxicity screening—offering faster, more predictive insights than cell assays and helping de-risk drug development before clinical trials. https://ow.ly/XgEV50YMk9o

From SLAS Technology: AI is changing the game in athlete monitoring. Using wearable sensors + LSTM models, the IPM-EFPM framework tracks exercise stress in real time—offering smarter insights to improve basketball training, fitness monitoring and athlete performance: https://ow.ly/UJcO50YMk8p

Join Glauco Souza, PhD (Greiner Bio-One) for the SLAS Technology Idea Exchange (TIE): Bridging Discovery, Imaging, and the Future. Explore how biochem & phenotypic screening, 3D bio, advanced imaging, AI and lab automation meet to transform workflows: https://ow.ly/st4S50YKp8i.

If you're attending SLAS Europe 2026, or curious about the topics that will be covered, explore the SLAS Discovery & SLAS Technology pre-reads curated by editors of each journal. SLAS Discovery pre-reads: https://bit.ly/4cFRrWB SLAS Technology pre-reads: https://bit.ly/4vywrJ1

SLAS2026 Sustainability Sponsor, My Green Lab, is this week's New Matter podcast guest. Tune in as James Connelly, CEO, discusses sustainability trends in life science research and provides his insight into the growing adoption of third-party certs: https://bit.ly/3PTaaFt.

Coming off their SLAS2026 NexusXp People’s Choice Award win, Jason Kelly, co-founder & CEO of Ginkgo Bioworks, is back for a behind-the-scenes look at how leading organizations are deploying automation within their labs. Learn more and reserve your spot: https://bit.ly/3OtESo7.

Bayesian beats standard stats for PROM risk. A Bayesian logistic model better identified infection markers (fever, CRP, fetal HR) and key risks—outperforming traditional regression in prediction accuracy. A smarter lens on maternal–fetal health: https://ow.ly/yh8v50YBY4f

The latest volume of SLAS Technology is now available via Open Access. This issue features 1 tech brief, 4 Original Research articles & 3 articles from the Revolutionizing Transcriptomics from Single-Cell Insights to RNA-Based Interventions Special Isue: https://bit.ly/4tsEhSm.

Thermal imaging meets cancer care. In a clinical trial, PF chemo + radiotherapy reduced tumor volume—and infrared scans tracked tumor response in real time, even flagging early tissue damage. A noninvasive boost for monitoring treatment + QoL. https://ow.ly/hbcS50YBXZH

Deep learning shows serious promise for CKD detection. An optimized dense neural network hit 99% accuracy (AUC 0.98), outperforming other models, highlighting its potential for early diagnosis and more reliable disease management. https://ow.ly/Urg550YBXU4

FastEffNet uses transformer-based knowledge distillation to make DR detection faster and lighter. An EfficientNet-B0 student model hits ~95% accuracy (AUC 0.99) with low compute—pointing to scalable, cost-effective screening without sacrificing performance. https://ow.ly/jIPN50YBXKM

The SLAS Applied Liquid Handling Bootcamp is back for a late spring session. For grad students looking to bridge the gap between coursework and real-world lab applications, this kind of hands-on experience can make all the difference. Learn more: https://bit.ly/4mdzkdR.

From SLAS Technology: qEEG could help predict stroke recovery early. In 167 acute ischemic stroke patients, EEG markers—especially DTABR & DAR—accurately forecast 3-month outcomes, even beyond NIHSS scores. A promising tool for sharper, earlier prognosis. https://ow.ly/xtWq50YBXEm

Join guest speaker Mat Todd, Head of Chemical Networks at @thesgc.bsky.social, for a discussion about Target 2035, a global open science initiative that brings together academia and industry to develop chemical probes for every human protein by 2035: https://bit.ly/48fsONO.

Cells are talking and we're finally able to listen. SLAS Technology guest editors are seeking research for the upcoming special issue, Emergent Electrophysiological Technologies. Learn more: https://bit.ly/3Ny7Pir.

Better healing, less discomfort: autologous CGF significantly reduces early pain and swelling after supernumerary tooth extraction and improves bone recovery at 3 months, supporting its role in enhanced postoperative outcomes. https://www.slas-technology.org/article/S2472-6303(25)00079-2/fulltext

Stroke subtypes, distinguished: HR-MRI reveals key differences in plaque features & risk factors between anterior/posterior circulation strokes linking diabetes to positive remodeling and highlighting smoking & uric acid as drivers of plaque vulnerability: https://ow.ly/5gSb50YxKcx

What does responsible AI use in scientific research actually look like? Join the SLAS Data Science & AI TIG Science Circle online Tuesday at 11:00 a.m. CDT for a follow-up virtual discussion building on the momentum from the onsite TIG meeting at SLAS2026: https://ow.ly/RjfJ50YzKR4

From SLAS Technology: Tumor microenvironment in action: CAF-derived exosomal miRNA-188–3p drives cervical cancer progression by rewiring iron metabolism—boosting tumor cell proliferation, migration, and metabolic activity. https://www.slas-technology.org/article/S2472-6303(25)00071-8/fulltext

We'd love for you to join us in Vienna this May for presentations and discussions involving advances in drug discovery, lab automation and screening applications and diagnostics. Early bird registration rates are available through this coming Monday 30 March. https://ow.ly/Jg0p50YyyON

From SLAS Technology: Endothelial dysfunction, decoded: integrating meta-analysis + Mendelian randomization, this study identifies vWF and E-selectin as causal drivers of ischemic stroke subtypes linking thrombosis & inflammation to stroke risk: https://ow.ly/AXsv50YxK44

Migraine mechanisms in focus: a rat model study links trigeminal ganglion activation to shifts in PTEN, Akt, and CREB expression—revealing a dynamic gene interplay that may help explain migraine onset and its higher prevalence in women: https://ow.ly/k20x50YxJWs

From phenomics and cell painting to machine learning–driven image analysis, our 4th annual joint special issue with the @sbi2.bsky.social will highlight the advances in high-content imaging are transforming how scientists study biology: https://ow.ly/cur250YxEEM

There are many ways you help the greater SLAS community as a volunteer. Join members of the SLAS Professional team next Wednesday at 11:00 a.m. CDT for a walk through of the ways you can get involved across the organization: https://ow.ly/6g3m50YwwYf.

CEO Vicki Loise is the latest guest on The Biotech Stack podcast. Tune in to hear more about our upcoming hands-on programming and how our community is navigating the growing role of AI and data management in lab automation. Check out the full episode: https://www.youtube.com/watch?v=kGdSnLwZwSk.

SNet, a deep learning model, boosts computer-aided diagnosis of gastrointestinal disease. Trained on HyperKvasir and tested on Kvasir v1/v2, this six-block CNN with MRMR feature selection overcomes poor contrast and irregular patterns in endoscopic images: https://ow.ly/joxH50YuYOm

By combining automated annotation via SIFT-based image registration with an enhanced Mask R-CNN architecture (AttFPN + spatial attention), researchers created a benchmark dataset and achieved higher precision, especially for small and medium chromosomes: https://ow.ly/79Oa50YuYIv

Using qPCR, RIP, CRISPR/Cas9 editing and thermal imaging–based metabolic monitoring, researchers show CircTNFRSF19 directly interacts w/ B3GNT5, boosting tumor cell metabolism and highlighting a potential therapeutic target in triple-neg breast cancer. https://ow.ly/JXNb50YuYB1

Are you working on breakthrough technologies in life sciences research, automation or drug discovery? Share your work with the global life sciences community by submitting your research for the opportunity to get published in an SLAS journal. Learn more: https://ow.ly/1Ep450YrU8p.

Our #SLASEurope2026 Technology Provider Showcase offers a behind-the-scenes look at innovation happening at the Vienna BioCenter. Half-day sessions will bring attendees into the labs to explore scientific approaches, tech integrations and workflows: https://ow.ly/fJaY50Ys1Of

Join Glauco Souza, PhD (Greiner Bio-One) for the SLAS Technology Idea Exchange (TIE): Bridging Discovery, Imaging, and the Future. Explore how biochem & phenotypic screening, 3D bio, advanced imaging, AI and lab automation meet to transform workflows: https://ow.ly/ipYK50YrQET.

Welcome to the European home team rotation, Geneva! We're excited to announce that we have signed a multi-year contract with the city of Geneva, Switzerland, who will now host our Europe Conference & Exhibition in 2028, 2030 and 2032: https://ow.ly/wTQP50Yp7fB.

We can’t stop talking about #SLAS2026 and neither can our media partners. Thanks to Zyme Communications and Biotechniques for this in depth overview of the breakthrough lab automation and life sciences technologies on display in Boston. https://ow.ly/2Mzz50YqtMc#SLAS2026

From the Biomed Imaging New Frontiers in Molecular and Cellular Visualization special issue: PDA@MT nanoparticles showed strong antioxidant activity, reduced ROS and improved respiratory function in OSA rat models. A promising nanotherapy approach. https://ow.ly/5euB50YoFEF

From the Lab of the Future/NexusXp special issue: This modular, SBS-compatible storage unit connects mobile robots with HTS workstations for seamless 24/7 sample transfer boosting throughput, flexibility and contamination-free handling. https://ow.ly/6Pac50YoFlP

Our first #SLASMeetUp of the year is happening Monday at the Bayer Life Hub in Lyon! We’re excited to bring the community together for an afternoon of science and networking, featuring two perspectives at the forefront of biotech innovation. Learn more: https://ow.ly/4u8l50YpK4q#SLASMeetUp

From the High-throughput mass spec in drug discovery special issue: A multiplexed 2D LC/MS + ultrafast acoustic ejection MS platform enables high-throughput binding screens w/ real-time cross-hit analysis boosting speed, scalability and data quality. Bristol Myers Squibb https://ow.ly/vW6v50YoF5h

From the High-throughput mass spectrometry in drug discovery special issue: By pairing acoustic ejection with high-res TOF MS (Echo® MS+ + ZenoTOF 7600), researchers from Biogen achieved 1–2 sec intact protein analysis from 384/1536-well plates. https://ow.ly/6qtc50YoEXb

The torch has been passed from Boston to Vienna. Meet the 12 startups named to the #SLASEurope2026 Innovation AveNEW: https://events.rdmobile.com/Exhibitors/Index/19692?Search=&sort=Name&display=Grid&mode=All&pagenumber=0&SelectedTags=109928#SLASEurope2026

From SLAS Technology: This GE study pairs multi-target paramagnetic beads with magnetic ratcheting to rapidly isolate 18 bacteria + model viruses directly from mL-scale samples (<30 min). PCR-ready, semi-automated, and built for scale. https://ow.ly/uvbB50YoENk

Before we head to #SLASEurope2026 in Vienna, we'll be making 2 stops in Europe. You're invited to join us next Monday at the Bayer Life Hub Lyon for an afternoon of presentations, discussion and networking sponsored by Beckman Coulter Life Sciences. Reserve your spot: https://ow.ly/Sq0c50YnQ7J#SLASEurope2026